Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Cumulus Neuroscience

Request full access

Accelerating CNS Clinical Trials

Belfast, United KingdomFounded 2015Biotech & Life Sciences

About Cumulus Neuroscience

We’re developing faster, more effective tools to help our partners solve the biggest healthcare challenges in neurodegeneration and psychiatry. Cumulus Neuroscience has created a next-generation integrated physiological and digital biomarker platform. In clinical trials it provides the critical data and insights needed to accelerate the delivery of more effective CNS drugs to patients. This addresses the significant unmet need for faster, more robust and cost-effective execution and evaluation of clinical trials in neuroscience.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2015
Headquarters
Belfast, United Kingdom
Employees
35
Open positions
None listed
Dealroom signal
83.3/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices, Health Platform
Sector
Biotech & Life Sciences, Biotechnology, Neurology, Cognitive, Clinical Trials, Tech for Biotech and Pharma, AI Drug Discovery, biotech medtech and e-health, Techbio
Business model
Manufacturing
Client focus
B2B

Funding history

10 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VC✓Equity / VC Jul 2025 $4.3M $73M Clarendon Fund Managers · Whiterock Finance · ACF Investors ↗
GRANT✓Other financing May 2024 $1.6M — UK Research and Innovation —
Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Growth signals

Cumulus Neuroscience website traffic

Latest recorded traffic for Cumulus Neuroscience is 190 monthly website visits, down 72.5% over the last three months. Cumulus Neuroscience's team grew 2.9% over the past year.

Latest monthly visits190 3-month web change-72.5% 1-year team growth+2.9%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Cumulus Neuroscience in the Belfast ecosystem

Live from Dealroom

The Cumulus Neuroscience office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

15 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed8 investors entered at this stage

  • Techstart Ventures
  • ACF Investors
  • Invest Northern Ireland
  • Kx Systems
  • Par Equity
  • Clarendon Fund Managers
  • British Business Investments
  • UK Research and Innovation

Series A4 investors entered at this stage

  • SV Health Investors
  • Dementia Discovery Fund
  • Future Fund
  • LifeArc

Series B and later1 investor entered at this stage

  • Whiterock Finance

Other known investors2 additional known investors

  • Tech Nation
  • PXN Group
Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
8 countries with
team presence
🇬🇧 United Kingdom60.7%
🇮🇪 Ireland10.7%
🇺🇸 United States7.1%
🇧🇩 Bangladesh3.6%
🇪🇸 Spain3.6%
Top 5 of 8 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Cumulus Neuroscience on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Cumulus Neuroscience’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.